Skip to main content
Dennis Selkoe, MD, Neurology, Boston, MA

DennisJSelkoeMD

Neurology • Boston, MA

The Vincent and Stella Coates Professor of Neurologic Diseases, Harvard Medical School; Co-Director, Center for Neurologic Diseases, Department of Neurology Brigham and Women’s Hospital.

Join to view full profile

Dr. Selkoe is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Selkoe's full profile

Already have an account?

  • Office

    60 Fenwood Road
    BTM 10 - 10002S
    Boston, MA 02115
    Phone+1 617-525-5260

Education & Training

  • Beth Israel Deaconess Medical Center/Harvard Medical School
    Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 1974 - 1975
  • Beth Israel Deaconess Medical Center/Harvard Medical School
    Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 1972 - 1973
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemInternship, Internal Medicine, 1969 - 1970
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 1969

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1974 - 2025
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Elected Member Institute of Medicine, 2005
  • Super Doctor SuperDoctors.com
  • Whos Who in Medicine and Healthcare Marquis Whos Who

Publications & Presentations

PubMed

Journal Articles

  • MicroRNA-132 Provides Neuroprotection for Tauopathies via Multiple Signaling Pathways  
    Dennis Selkoe, MD, Acta Neuropathologica

Authored Content

  • CMS Made the Wrong Decision on Aduhelm. But There Might Be a Silver LiningApril 2022

Press Mentions

  • Eisai to Present Dual-Acting Lecanemab Three Year Efficacy and Safety Data and Discuss Long-Term Outcomes of Continued Treatment at the Alzheimer's Association International Conference 2024
    Eisai to Present Dual-Acting Lecanemab Three Year Efficacy and Safety Data and Discuss Long-Term Outcomes of Continued Treatment at the Alzheimer's Association International Conference 2024July 22nd, 2024
  • Brigham Experts Offer Insights on Lecanemabs Alzheimers Benefits
    Brigham Experts Offer Insights on Lecanemabs Alzheimers BenefitsMay 11th, 2023
  • Scientists Shed New Light on Two Proteins That Exacerbate the Progression of Parkinson's Disease
    Scientists Shed New Light on Two Proteins That Exacerbate the Progression of Parkinson's DiseaseMarch 28th, 2023
  • Join now to see all

Grant Support

  • Structure-Function Relationships In Presenilin/Y-SecretaseNational Institute On Aging2008–2011
  • PROTEIN-PROTEIN Interactions In The Biology Of Beta-AppNational Institute On Aging2008–2011
  • Presenilin Biology And The Mechanism Of Alzheimer'S DiseaseNational Institute On Aging2008–2011
  • Administrative And Educational CoreNational Institute On Aging2008–2011
  • Aging In The Brain: The Role Of The Fibrous ProteinsNational Institute On Aging2007–2011
  • Pathogenic Mechanisms Of Cell-Derived Abeta OligomersNational Institute On Aging2006–2011
  • Alpha-Synuclein, PUFA And Membrane Vesicles In Health And Parkinson'S DiseaseNational Institute Of Neurological Disorders And Stroke2007–2010
  • Amyloid B-Protein And Immune Markers In Human BloodNational Center For Research Resources2007–2008
  • Purification And Reconstitution Of Active Gamma Secretase ComplexNational Institute On Aging2007
  • Administrative CoreNational Institute On Aging2007
  • PROTEIN-PROTEIN Interactions In The Biology Of Beta APPNational Institute On Aging2003–2007
  • Presenilin Biology And Mechanism Of Alzheimer'S DiseaseNational Institute On Aging2003–2007
  • Alpha-Synuclein, PUFA And Membrane Vesicles-Health/PdNational Institute Of Neurological Disorders And Stroke2006
  • Aging In The Brain-Role Of The Fibrous ProteinsNational Institute On Aging2003–2006
  • Amyloid Precursor Protein In Human BloodNational Center For Research Resources2004–2005
  • Aging In The Brain-Role Of The Fibrous ProteinsNational Institute On Aging2002
  • Mechanism And Inhibition Of Native Amyloid Beta Aggregation In CellsNational Institute On Aging1999–2002
  • Presenilin Genotype To Phenotype Conversion And Gamma SecretaseNational Institute On Aging1998–2002
  • Presenilin Biology &The Mechanism Of Alzheimers DiseaseNational Institute On Aging1998–2002
  • Protein/Protein Interactions In The Biology Of Beta AmylNational Institute On Aging1999–2001
  • Aging In The Brain--Role Of The Fibrous ProteinsNational Institute On Aging1992–2000
  • Purification /Reconstitution Of Active Gamma SecretaseNational Institute On Aging1999
  • Protein/Protein Interactions In The Biology Of Beta APPNational Institute On Aging1995–1998
  • Regulation Of Amyloid Beta Production In Health And Alzheimer'S DiseaseNational Institute On Aging1994–1998
  • Leadership And Excellence In Alzheimers DiseaseNational Institute On Aging1994
  • Aging In The Brain: Role Of The Fibrous ProteinsNational Institute On Aging1991–1993
  • Leadership And Excellence In Alzheimer'S DiseaseNational Institute On Aging1988–1993
  • Molecular Pathology Of Alzheimer Paired Helical FilamentNational Institute On Aging1987–1989
  • Aging In The Brain--Role Of The Fibrous ProteinsNational Institute On Aging1985–1989
  • Purification Of Paired Helical FilamentsNational Institute On Aging1985–1988
  • Molecular Pathology Of Alzheimer Paired Helical FilamentNational Institute Of Neurological Disorders And Stroke1985–1986
  • Molecular Pathology Of Alzheimer Paired Helical FilamentNational Institute Of Neurological Disorders And Stroke1985

Dr. Dennis Selkoe, Dr. Dennis Selkoe, MD, Dr. D Selkoe, Dr. Dennis J Selkoe